Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Jul 22;44(7):115907.
doi: 10.1016/j.celrep.2025.115907. Epub 2025 Jun 26.

Evolution of SARS-CoV-2 T cell responses as a function of multiple COVID-19 boosters

Affiliations
Free article

Evolution of SARS-CoV-2 T cell responses as a function of multiple COVID-19 boosters

Ricardo da Silva Antunes et al. Cell Rep. .
Free article

Abstract

We investigate the long-term impact of repeated COVID-19 vaccinations on adaptive immunity through a 3-year study of 78 individuals without reported symptomatic infections. We observe distinct dynamics in spike-specific responses across multiple vaccine doses. While antibody levels increase and stabilize with each booster, T cell responses quickly plateau and remain stable. Notably, approximately 30% of participants show evidence suggestive of asymptomatic infections. Single-cell RNA sequencing reveals a diverse and stable landscape of spike-specific T cell phenotypes without signs of exhaustion or functional impairment. Individuals with evidence of asymptomatic infection display increased frequencies of Th17-like CD4+ T cells and GZMKhi/IFNR+ CD8+ T cell subsets. In this group, repeated vaccinations correlate with an increase in regulatory T cells, potentially indicating a balanced immune response that may mitigate immunopathology. By regularly stimulating T cell memory, boosters contribute to a stable and enhanced immune response, which may provide better protection against symptomatic infections.

Keywords: COVID-19; CP: Immunology; SARS-CoV-2; T cell responses; antibody responses; asymptomatic infection; booster vaccination; exhaustion; mRNA vaccines; scRNA-seq.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests A.S. is a consultant for Darwin Health, EmerVax, Gilead Sciences, Guggenheim Securities, RiverVest Venture Partners, and Arcturus. D.W. is a consultant for Moderna. S.C. has consulted for GSK, JP Morgan, Citi, Morgan Stanley, Avalia NZ, Nutcracker Therapeutics, University of California, California State Universities, United Airlines, Adagio, and Roche. LJI has filed for patent protection for various aspects of T cell epitope and vaccine design work.

Update of

MeSH terms

LinkOut - more resources